X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with Biocon Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs BIOCON LTD - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

BIOCON LTD 
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD BIOCON LTD STRIDES SHASUN LTD/
BIOCON LTD
 
P/E (TTM) x 15.3 72.6 21.0% View Chart
P/BV x 1.8 6.8 25.9% View Chart
Dividend Yield % 0.6 0.2 308.5%  

Financials

 STRIDES SHASUN LTD   BIOCON LTD
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-17
BIOCON LTD
Mar-17
STRIDES SHASUN LTD/
BIOCON LTD
5-Yr Chart
Click to enlarge
High Rs1,2751,162 109.7%   
Low Rs918483 190.3%   
Sales per share (Unadj.) Rs389.6194.6 200.2%  
Earnings per share (Unadj.) Rs28.034.4 81.3%  
Cash flow per share (Unadj.) Rs48.948.3 101.3%  
Dividends per share (Unadj.) Rs4.501.00 450.0%  
Dividend yield (eoy) %0.40.1 337.5%  
Book value per share (Unadj.) Rs303.1241.9 125.3%  
Shares outstanding (eoy) m89.42200.00 44.7%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.84.2 66.6%   
Avg P/E ratio x39.223.9 164.0%  
P/CF ratio (eoy) x22.417.0 131.6%  
Price / Book Value ratio x3.63.4 106.4%  
Dividend payout %16.12.9 553.6%   
Avg Mkt Cap Rs m98,036164,440 59.6%   
No. of employees `0005.89.2 62.8%   
Total wages/salary Rs m5,8817,470 78.7%   
Avg. sales/employee Rs Th6,005.94,213.9 142.5%   
Avg. wages/employee Rs Th1,014.0809.0 125.3%   
Avg. net profit/employee Rs Th431.2745.2 57.9%   
INCOME DATA
Net Sales Rs m34,83438,911 89.5%  
Other income Rs m1,6861,571 107.3%   
Total revenues Rs m36,52040,482 90.2%   
Gross profit Rs m6,4289,795 65.6%  
Depreciation Rs m1,8722,772 67.5%   
Interest Rs m2,269260 872.8%   
Profit before tax Rs m3,9738,334 47.7%   
Minority Interest Rs m0163 0.0%   
Prior Period Items Rs m40-   
Extraordinary Inc (Exp) Rs m-1,0060-   
Tax Rs m4701,616 29.1%   
Profit after tax Rs m2,5016,881 36.3%  
Gross profit margin %18.525.2 73.3%  
Effective tax rate %11.819.4 61.0%   
Net profit margin %7.217.7 40.6%  
BALANCE SHEET DATA
Current assets Rs m38,16540,477 94.3%   
Current liabilities Rs m30,40216,783 181.1%   
Net working cap to sales %22.360.9 36.6%  
Current ratio x1.32.4 52.1%  
Inventory Days Days7760 129.8%  
Debtors Days Days10483 126.1%  
Net fixed assets Rs m37,63945,073 83.5%   
Share capital Rs m8941,000 89.4%   
"Free" reserves Rs m26,21047,377 55.3%   
Net worth Rs m27,10548,377 56.0%   
Long term debt Rs m16,37721,082 77.7%   
Total assets Rs m81,16893,942 86.4%  
Interest coverage x2.833.1 8.3%   
Debt to equity ratio x0.60.4 138.7%  
Sales to assets ratio x0.40.4 103.6%   
Return on assets %5.97.6 77.3%  
Return on equity %9.214.2 64.9%  
Return on capital %12.112.6 95.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m13,46512,988 103.7%   
Fx outflow Rs m4,0767,899 51.6%   
Net fx Rs m9,3895,089 184.5%   
CASH FLOW
From Operations Rs m2,8816,400 45.0%  
From Investments Rs m-7,051-4,985 141.4%  
From Financial Activity Rs m3,382-1,775 -190.5%  
Net Cashflow Rs m-788-473 166.5%  

Share Holding

Indian Promoters % 27.7 40.4 68.6%  
Foreign collaborators % 0.0 20.6 -  
Indian inst/Mut Fund % 37.8 8.4 450.0%  
FIIs % 8.6 10.7 80.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.9 19.9 130.2%  
Shareholders   56,241 109,995 51.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   WYETH LTD  PIRAMAL ENTERPRISES  JUBILANT LIFE SCIENCES  FRESENIUS KABI ONCO.  GLENMARK PHARMA  

Compare STRIDES SHASUN LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Above 35,000 Mark; Bank & IT Stocks Outperform(Closing)

After opening the day flat, share markets in India witnessed positive trading activity throughout the day and ended the day on a strong note.

Related Views on News

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Jan 17, 2018 (Close)

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD 8-QTR ANALYSIS

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS